Finland· FI-REL-REL2111

Nimotop

A nimodipine product containing nimodipine, registered in Finland by Laboratoire X.O. The same ATC class is registered in 14 of our 19 countries.

ATC C08CA06

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedNimotopATCC08CA06REGISTER NO.FI-REL-REL2111PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Nimodipine is registered in 14 of 19 countries.

Countries holding a registration under ATC C08CA06 (nimodipine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose

Nimodipine · ATC C08CA06

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nimodipine costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $5.28 in France to $7.99 in Switzerland — a ×1.5 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Nimodipine · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$7.99
  • FR France$5.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Nimodipine
Manufacturer
Laboratoire X.O
Country
Finland (FI)
ATC code
C08CA06
ATC class
Nimodipine
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    086553
    100
    EUR 219.95

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

202 interactions on record for nimodipine.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Nimodipine · interactions on record

202 records

  • 15 severe
  • 164 moderate
  • 1 minor
  • 20 info

Most severe, free to view

  • DolasetronA04AA04severe
  • KetoconazoleH02CA03severe
  • ClarithromycinJ01FA09severe
  • KetoconazoleJ02AB02severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nimodipine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nimodipine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Nimotop
  • Belgium · Nimotop
  • Bulgaria · Нимотоп S
  • Cyprus · Nemotan
  • Czechia · Dilceren, Nimotop S
  • Germany · Nimodipin Carinopharm, Nimodipin Ethypharm
  • Denmark · Nimotop
  • Estonia · Nimotop
  • Spain · Brainal, Nimodipino Altan
  • France · Nimodipine Altan, Nimotop
  • United Kingdom (Northern Ireland) · Nimotop
  • Greece · Befimat, Curban
  • Croatia · Nimotop S
  • Ireland · Nimotop
  • Italy · Iskidrop, Nimobrain
  • Luxembourg · Nimotop
  • Latvia · Nimotop
  • Netherlands · Nimotop
  • Norway · Nimotop
  • Poland · Nimotop S
  • Portugal · Brainox, Modina
  • Romania · Nimotop
  • Sweden · Nimotop
  • Slovenia · Nimodipin Bayer, Nimodipin Laboratoire X.O
  • Slovakia · Dilceren Pro Infusione, Nemotan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4b034ad4-822f-47a7-8057-1cfe78bfc65b
GET /v1/drugs/4b034ad4-822f-47a7-8057-1cfe78bfc65b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.3",
  "form": "tabletti, kalvopäällysteinen",
  "route": "Suun kautta",
  "ddd_unit": "g",
  "strength": "30 mg",
  "atc_label": "nimodipiini",
  "ma_number": "9470",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL2111",
  "authorised_at": "1987-04-23"
}

See everything about nimodipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.